OTCMKTS: IVRN
Product Pipeline
Innoveren Scientific has a balanced product pipeline of both short and long-term opportunities, which position the Company to not only achieve operational success but also maximize return on investment.
2024 Milestone Timeline
| Current Product Pipeline | Q4 2023 | Q1-Q2 2024 | Q3-Q4 2024 | Q1-Q2 2025 |
|---|---|---|---|---|
| SkinDisc™ Lite | FDA Submission (510(k) | FDA Clearance | Reimbursement Coding | |
| Clinical Wound Healing | Step 1
|
Step 2
|
Step 3
|
|
| SkinDisc™ | FDA Submission De Novo Preparation | FDA Submission De Novo | ||
| Limb Salvage | Step 1
|
Step 2
|
||
| BreathEasy | Prospective Clinical Study | FDA Supplement Data Submission | Reimbursement Coding | |
| COPD Management | Step 1
|
Step 2
|
Step 3
|
|
© 2024 Innoveren Scientific Inc. All Rights Reserved. Powered by Issuer Direct.
Contact Us
IVRN@alpha-ir.com
312-445-2870
151 W 4th St. Ste 223
Cincinnati, OH 45202